Skip to main navigation Skip to search Skip to main content

Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in Patients With Cardiogenic Shock: A Systematic Review and Meta-Analysis

  • Kyriakos Dimitriadis*
  • , Stergios Soulaidopoulos
  • , Nikolaos Pyrpyris
  • , Μarios Sagris
  • , Konstantinos Aznaouridis
  • , Eirini Beneki
  • , Panagiotis Theofilis
  • , Panagiotis Tsioufis
  • , Fotis Tatakis
  • , Christos Fragkoulis
  • , Mony Shuvy
  • , Christina Chrysohoou
  • , Konstantina Aggeli
  • , Konstantinos Tsioufis
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

BACKGROUND: Patients with severe mitral regurgitation and cardiogenic shock demonstrate a poor prognosis. Mitral transcatheter edge-to-edge repair could alter patient management. METHODS AND RESULTS: We systematically reviewed PubMed/Medline, Scopus, and Cochrane Library until January 2023, including studies assessing transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock. Studies with <5 patients were excluded. The primary outcome was device success and all-cause death, while secondary outcomes included myocardial infarction, stroke, and heart failure hospitalization rates at 30-day and intermediate-term follow-up. A fixed-effects meta-analysis was used to estimate pooled rates. Risk of bias was assessed with the Newcastle– Ottawa Scale. A total of 24 studies and 5428 patients were included, with a mean age of 71.2±3.3 years and a high mean Society of Thoracic Surgery score (15.2±8.9). Device success was achieved in 86% (95% CI, 85%–87%) and mitral regurgitation ≤2+ in 89% (95% CI: 88%–90%). The 30-day all-cause mortality rate was 14% (95% CI, 13%–15%). Stroke, myocardial infarction, and heart failure hospitalization rates were 2% (95% CI, 1%–2%), 15% (95% CI, 13%–18%), and 9% (95% CI, 8%– 10%), respectively. Patients with acute myocardial infarction had similar device success (81% [95% CI, 74%–87%]), a 30-day mortality rate of 20% (95% CI, 16%–25%), and intermediate-term mortality rate of 14% (95% CI, 9%–19%). In non–myocardial infarction populations, the 30-day mortality rate was 13% (95% CI, 13%–14%), and the intermediate-term mortality rate was 35% (95% CI, 34%–36%). CONCLUSIONS: In patients with mitral regurgitation and cardiogenic shock, transcatheter edge-to-edge repair is associated with favorable 30-day and intermediate-term outcomes. Limitations, including the observational design of included studies and considerable heterogeneity, necessitate further research in this setting.

Original languageEnglish
Article numbere034932
JournalJournal of the American Heart Association
Volume14
Issue number6
DOIs
StatePublished - 18 Mar 2025

Bibliographical note

Publisher Copyright:
© 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • MitraClip
  • TEER
  • cardiogenic shock
  • mitral regurgitation
  • myocardial infarction
  • transcatheter edge-to-edge repair

Fingerprint

Dive into the research topics of 'Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation in Patients With Cardiogenic Shock: A Systematic Review and Meta-Analysis'. Together they form a unique fingerprint.

Cite this